iOnctura
Company

Last deal

$85.9M
Local Amount - EUR 80M

Amount

Series B

Stage

20.06.2024

Date

3

all rounds

$127.72M

Total amount

date founded

Financing round

General

About Company
iOnctura is a clinical-stage biotech developing next-generation bio-molecules for the treatment of cancer and fibrosis.

Industry

Sector :

Subsector :

Keywords :

founded date

01.06.2017

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

The company's bio-molecules include novel therapeutics that modulate key culprits of immunosuppression in the tumor microenvironment, enabling doctors to treat diseases such as cancer faster. iOnctura has progressed two therapeutic candidates into mid-stage clinical development: IOA-244, a highly selective allosteric inhibitor of PI3Kδ to treat Treg-driven tumors; and IOA-289, a highly selective, non-competitive autotaxin (ATX) inhibitor to treat cancer associated fibroblast (CAF) driven tumors. iOnctura is backed by specialist institutional investors including M Ventures, Inkef Capital, VI Partners, Schroders Capital, and 3B Future Health Fund.
Contacts

Contact Email

Social url

Similar Companies
999
Intezyne Technologies

Intezyne Technologies

Intezyne Technologies develops synthetic polymers for drug delivery and the treatment of cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Biopharma

Location

Tampa, FL, USA

total rounds

2

total raised

$10.48M
CytoVac

CytoVac

Cytovac is a clinical-stage biopharmaceutical company developing individualized cell-based therapies for solid tumors.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

2970 Hørsholm, Denmark

total rounds

1

total raised

$2.2M
PCI Biotech Holding ASA

PCI Biotech Holding ASA

PCI Biotech is a biopharmaceutical company focused on cancer treatment therapies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Biopharma

Location

Oslo, Norway
Izana Bioscience

Izana Bioscience

Izana Bioscience is a biopharmaceutical company developing innovative science to market.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Oxford, UK

total rounds

1

total raised

$1.81M

Financials

Funding Rounds
9
3

Number of Funding Rounds

$127.72M

Money Raised

Their latest funding was raised on 20.06.2024. Their latest investor 3B Future Health Fund. Their latest round Series B

Date 
Funding Round 
Investors 
Money Raised 
Lead 
20.06.2024
7
$85.9M
Local Amount - EUR 80M
15.05.2024
1
$398K
Local Amount - EUR 367.73K
03.05.2023
2
Syncona Partners LLP

Syncona Partners LLP

Syncona Partners LLP is a healthcare company that invests in and builds global leaders in life science.

Sector

Health Care Providers

Subsector

Health Care Services

Keywords

Health Care, Financial Services, Venture Capital

Location

London, UK

count Of Investments

41

count Of Exists

4
KWF Kankerbestrijding

KWF Kankerbestrijding

KWF Kankerbestrijding: Dutch non-profit fighting cancer through research, medicine, and support.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Non-Profit, Health Care

Location

Amsterdam, Netherlands

count Of Investments

2
Co-Investors
Investors
11
4

Number of lead investors

11

Number of investors

Investor 
Lead 
Round 
Partners 
No
Series B
No
Series B
3B Future Health Fund

3B Future Health Fund

Helsinn Investment Fund is a Luxembourg-based fund that focuses on early-stage investments in areas of high unmet patient need.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Munich, Germany

count Of Investments

30

count Of Exists

1
Schroders Capital

Schroders Capital

Schroders Capital is a global private markets business offering specialized investment services.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

London, UK

count Of Investments

20
Inkef

Inkef

Inkef is a venture capital firm that invests in European technology and healthcare companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Finance

Location

Amsterdam, Netherlands

count Of Investments

77

count Of Exists

13

People

Founders
1
Catherine Pickering
Catherine Pickering

Catherine Pickering

Catherine holds a PhD in Medicinal Chemistry from The Institute of Cancer Research, London and an MBA from Henley Management College, UK. She is an experienced deal maker with broad transaction experience including licensing (in- and out licensing, option deals, and strategic collaborations) and M&A. During her time at Merck where she lead the global oncology and immuno-oncology licensing and business development function she was also part of the oncology franchise leadership team, a small cross functional team responsible for creating the strategy for the oncology business. She has also held business development and alliance management positions in small biotech and started her career in technology transfer at The Institute of Cancer Research. Her longstanding experience in the healthcare industry gives her a wide network across research institutions and with c-levels in biotech and pharma.

current job

iOnctura
iOnctura

organization founded

1

Catherine Pickering

Employee Profiles
3
Sean A. MacDonald

Sean A. MacDonald

Chief Business Officer

Joanna C. Horobin

Non Executive Chair of the Board of Directors

Catherine Pickering

Catherine Pickering

CEO

Activity

Recent News
11
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

week